SOURCE: Trident Brands, Inc.

Trident Brands, Inc.

June 17, 2016 08:34 ET

Brain Armor® Joins Vendor Central Program

BROOKFIELD, WI--(Marketwired - Jun 17, 2016) -  Trident Brands, Incorporated (OTCQB: TDNT), an emerging growth company focused on identifying and building growth brands in dynamic consumer segments, today announced the commencement of Brain Armor® sales under the Vendor Central program.

Brain Armor® is one of the highest single dose capsules of plant based DHA on the market. It is NSF certified for sport, and has garnered a following with professional and collegiate athletes. Brain Armor® features life'sDHA®, a plant based DHA sourced from a sustainable process in an FDA inspected facility. life'sDHA® is a trusted source; it is used in over 99% of infant formulas in the US.

DHA is especially concentrated in the gray matter of the brain, the retina of the eyes and heart tissue. DHA represents 97 percent of the omega-3s in the brain.

Vendor Central is an invitation only trade relationship designation that will offer Brain Armor® as sold and shipped by The Vendor Central program elevates product visibility and provides access to a range of promotions including Amazon Vine, Subscribe & Save, and analytics.

"Consumers have demonstrated a strong preference for purchasing nutrition products online," explains Don MacPhee, Trident Brands President. "We believe we have a powerful brand - the very best DHA supplement you can buy. We also believe that a big driver of our future success will be the distribution power of Vendor Central and consumer trust associated with"

Trident Brands holds an exclusive worldwide license from Royal DSM to market Brain Armor® 

Brain Armor® joins Trident Brands' other nutrition products line, Everlast Nutrition, in the Amazon Vendor Central program.

About DSM

Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders simultaneously. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM and its associated companies deliver annual net sales of about EUR 10 billion with approximately 25,000 employees. The company is listed on Euronext Amsterdam. More information can be found at

About Trident Brands Incorporated

Trident Brands, Incorporated is an emerging growth company focused on identifying and building growth brands in dynamic consumer segments. Trident is currently targeting growth opportunities in consumer goods such as functional foods, supplements, and beverages, life science technologies that have applications in consumer products, and intellectual property and/or licenses in recognized brand platforms. Trident Brands holds a 15-year license to market and sell products in the nutritional foods and supplements category under the Everlast® brand. The Everlast® Nutrition line includes Everlast® Vegan Protein, Everlast® Fuel hydration drink mix, and Everlast® Burn metabolism boost. Everlast® is owned by International Brand Management and Licensing (IBML), a worldwide leader in brand licensing. Trident Brands also holds an exclusive worldwide license from Royal DSM to market Brain Armor®. A pure plant based DHA sourced from a sustainable process in an FDA inspected facility, Brain Armor® is the highest single capsule dose of plant based DHA on the market; it has a strong following among professional and collegiate athletes. Trident Brands holds a 10-year renewable license from Oceans Omega to market clear, stable, emulsions -patented innovation in liquid Omega 3 ingredients. Trident Brands will sell and distribute Oceans Omega emulsions through Mitsubishi Food Ingredients International (MIFI).

Forward-Looking Statements

This press release contains "forward-looking statements" within the meaning of the "safe-harbor" provisions of the Private Securities Litigation Reform Act of 1995 that are not historical facts. These statements can be identified by the use of forward-looking terminology such as "believe," "expect," "may," "will," "should," "project," "plan," "seek," "intend," or "anticipate" or the negative thereof or comparable terminology, and include discussion about the completion of a commercial arrangement with Such statements involve known and unknown risks, uncertainties and other factors that could cause the Company's actual results to differ materially from the results expressed or implied by such statements. Such risks and uncertainties include, without limitation, market acceptance of the Company's forthcoming line of nutritional products; the Company's compliance with applicable Food and Drug Administration regulations; the Company's reliance on third-party contractors to mix and produce its products; the Company's ability to develop an effective marketing strategy; the Company's ability to control advertising and marketing costs; the Company's ability to develop and increase awareness of its forthcoming brands; the success of the Company's marketing focus to retail buyers; the Company's exposure to product liability claims and intellectual property claims from third parties; and the Company's reliance on the expected growth in demand for its products. For a discussion of these and other risks and uncertainties see "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in the Company's public filings with the SEC. Although the Company believes that the expectations reflected in such forward-looking statements are reasonable, there can be no assurance that such expectations will prove to be correct. The Company has no obligation to update the forward-looking information contained in this press release.

Contact Information